ArticleJournal of thrombosis and thrombolysis2026
Beyond Platelet Destruction: A Mechanistic Understanding of Dengue Virus Non-Structural Proteins and Gene Regulatory Networks Driving Thrombocytopenia.
Article in Journal of thrombosis and thrombolysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombocytopenia is a defining and prognostically relevant feature of dengue virus infection, yet its mechanistic basis remains incompletely resolved. Classical models have emphasized immune-mediated platelet destruction or transient bone marrow suppression as independent causes of platelet loss. Increasing evidence, however, suggests that these explanations fail to capture the depth, persistence, and severity-dependent amplification of thrombocytopenia, which appears to arise from a coordinated failure of immune-haematopoietic homeostasis driven by viral perturbation of host immune and metabolic networks. To define this framework, a meta-analysis of two independent whole-blood transcriptomic datasets (GSE18090 and GSE51808), integrating patient-derived gene expression signatures with systematic synthesis of 37 mechanistic studies was performed. Across cohorts, dengue infection was characterized by robust activation of innate antiviral and interferon driven programs alongside reproducible repression of megakaryocyte and platelet biogenesis pathways. These transcriptional changes were not restricted to terminal platelet genes but extended to mitochondrial translation, ribosomal assembly, and cytoskeletal regulators essential for effective megakaryocyte maturation. Network integration revealed that dengue viral proteins, particularly non-structural protein 1 (NS1), act as upstream immune perturbators that couple innate immune sensing to endothelial disruption, metabolic reprogramming and accelerated platelet clearance. Together, these findings reposition dengue-associated thrombocytopenia as an emergent systems-level immunopathology rather than a singular consequence of platelet destruction. The integrated immune haematopoietic network framework explains severity dependent platelet loss through convergent defects in platelet production, functional integrity, and survival, and provides platelet homeostasis during dengue infection.
Indexed as
Identifiers
42493733What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.